INS and Insulin resistance: In the liver, IR presents as “selective hepatic insulin resistance”: insulin’s ability to suppress gluconeogenesis is diminished, resulting in fasting hyperglycemia, whereas its stimulatory effect on DNL remains intact or even enhanced (41).